Each year more than 100,000 people die from alcohol-related problems. Worldwide, more than 30 million people are either drug or alcohol dependant. But an experimental treatment could help many people to stay sober. Naltrel is a drug designed to stop cravings and block the effects of alcohol.
Clinical trials are underway.
The drug is expected to be on the market later this year. Naltrel is approved in 30 countries as an oral dosage for the prevention of relapse in alcohol and opiate addictions. Instead of taking pills, patients are given a shot once a month. Naltrel would be injected monthly to help alcoholics and opiate addicts kick their habits. Medical experts have stated that addictions are chemically based.